ZEG Berlin

ZEG Berlin is a premier international contract research organization (CRO) specializing in pharmacoepidemiology and post-authorization safety studies (PASS). Founded in 1991 and headquartered in Berlin, the company provides high-quality real-world evidence (RWE) through the design and execution of large-scale observational studies and registries. Their work is critical for monitoring the safety and effectiveness of pharmaceutical products in real-world settings, with a particular emphasis on women's health and cardiovascular outcomes. Now part of Cerner Enviza, an Oracle company, ZEG Berlin continues to serve the global life sciences industry by bridging the gap between clinical research and public health.